Abstract: The present invention relates to pharmaceutical compositions and kits comprising pharmaceutical compositions, and methods for administering pharmaceutical compositions comprising active contraceptive drugs in a patient. Specifically, the pharmaceutical compositions may comprise progestogen-only contraceptives (“POC”), such as Drospirenone.

Abstract: The present invention relates to non-hormonal compositions and methods for inducing a condition of aspermia, azoospermia, or severe oligozoospermia in the male subject such that these compositions and methods for administering the same may be used as male contraception. Embodiments of the present invention may comprise a composition comprising an alpha-1-adrenoreceptor antagonist, such as (R)-silodosin, for daily administration to a male subject. The compositions and related methods may further include pharmaceutically acceptable carriers. The present invention further includes formulations which allow for a delay such that delayed or missed dose(s) do not nullify the contraceptive effect of the treatment regimen. Such compositions and methods may also avoid the side effects associated with typical formulations of alpha-1-adrenoreceptor antagonists.

Abstract: The present invention relates to pharmaceutical compositions and kits comprising pharmaceutical compositions, and methods for administering pharmaceutical compositions comprising active contraceptive drugs in a patient. Specifically, the pharmaceutical compositions may comprise progestogen-only contraceptive (“POC”), such as Drosphirenone.

Abstract: The present invention relates to pharmaceutical compositions and kits comprising pharmaceutical compositions, and methods for administering pharmaceutical compositions comprising active contraceptive drugs in a patient. Specifically, the pharmaceutical compositions may comprise progestogen-only contraceptives (“POC”), such as Drospirenone.

Abstract: A map pocket assembly is provided with a seat back panel adapted to attach to a seat back, a map pocket panel coupled to the seat back panel and moveable between a closed position and an open position relative to the seat back panel to define a pocket opening therebetween, and a spring arm coupling the seat back panel to the map pocket panel to bias the map pocket panel to the closed position. The spring arm has first and second spring fingers extending from a spring base coupled to one of the seat back panel and the map pocket panel. The first and second spring fingers are moved to a spring angle relative to each other when the map pocket panel is moved to the open position that is greater than the spring angle when the map pocket panel is in the closed position.

Abstract: A pharmaceutical composition comprising an active contraceptive drug and one or more pharmaceutically-acceptable excipients. The pharmaceutical composition, when subjected to an in vitro dissolution test according to the USP XXIII Paddle Method, results in no more than 50% of said active drug initially present being dissolved within 30 minutes, and at least 50% of the active drug being dissolved in a time range from about 3 hours to about 4 hours. The pharmaceutical composition is administered daily to a patient having a BMI of about 25 kg/m2 or more for at least a portion of a treatment cycle. The pharmaceutical composition does not cause a number of days of bleeding events in the patient exceeding an average of 15% per treatment cycle in consecutive treatment cycles of administration after an initial treatment cycle of administration.

Abstract: A method and device for assisting initiation of a flare maneuver of an aircraft during a landing. The device includes an acquisition unit for acquiring current values of flight parameters of the aircraft, including the current height of the aircraft with respect to the ground, a computation unit for computing a first reference height and a second reference height, corresponding to a height starting from which the aircraft attains a current start of flare height while maintaining its current descent conditions over a predetermined first duration and over a predetermined second duration respectively, and an acoustic emission unit for emitting at least two sound signals in the cockpit of the aircraft, namely a first sound signal when the current height of the aircraft attains the first reference height during the descent and a second sound signal when the current height of the aircraft attains the second reference height during descent.

Abstract: A map pocket assembly is provided with a seat back panel adapted to attach to a seat back, a map pocket panel coupled to the seat back panel and moveable between a closed position and an open position relative to the seat back panel to define a pocket opening therebetween, and a spring arm coupling the seat back panel to the map pocket panel to bias the map pocket panel to the closed position. The spring arm has first and second spring fingers extending from a spring base coupled to one of the seat back panel and the map pocket panel. The first and second spring fingers are moved to a spring angle relative to each other when the map pocket panel is moved to the open position that is greater than the spring angle when the map pocket panel is in the closed position.

Abstract: A method and device for assisting initiation of a flare maneuver of an aircraft during a landing. The device includes an acquisition unit for acquiring current values of flight parameters of the aircraft, including the current height of the aircraft with respect to the ground, a computation unit for computing a first reference height and a second reference height, corresponding to a height starting from which the aircraft attains a current start of flare height while maintaining its current descent conditions over a predetermined first duration and over a predetermined second duration respectively, and an acoustic emission unit for emitting at least two sound signals in the cockpit of the aircraft, namely a first sound signal when the current height of the aircraft attains the first reference height during the descent and a second sound signal when the current height of the aircraft attains the second reference height during descent.

Abstract: A device for assisting in the landing of an aircraft in a flare phase comprising a control stick, a first unit for acquiring current flight parameters of the aircraft, a second unit for acquiring a current deflection angle of the control stick, a computation unit for computing a difference between the current deflection angle of the control stick and a target deflection angle of the control stick, and an acoustic emission unit configured to automatically emit a warning or guidance sound signal in the cockpit of the aircraft, according to the difference between the current deflection angle and the target deflection angle of the control stick.

Abstract: A pharmaceutical composition comprising an active contraceptive drug and one or more pharmaceutically-acceptable excipients. The pharmaceutical composition, when subjected to an in vitro dissolution test according to the USP XXIII Paddle Method, results in no more than 50% of said active drug initially present being dissolved within 30 minutes, and at least 50% of the active drug being dissolved in a time range from about 3 hours to about 4 hours. The pharmaceutical composition is administered daily to a patient having a BMI of about 25 kg/m2 or more for at least a portion of a treatment cycle. The pharmaceutical composition does not cause a number of days of bleeding events in the patient exceeding an average of 15% per treatment cycle in consecutive treatment cycles of administration after an initial treatment cycle of administration.

Abstract: A method for improving a nutritional status in a prenatal, pregnant or breastfeeding patient. The method includes providing a pharmaceutical composition in a single oral dosage form for administration to a prenatal, pregnant or breastfeeding patient. The pharmaceutical composition consists of vitamin D, iodine, vitamin B1, vitamin B6, vitamin B12, vitamin B2, vitamin B9, vitamin B3, vitamin E, vitamin A, vitamin C, iron, zinc, copper, magnesium, omega-3 fatty acids and one or more pharmaceutically acceptable carriers. The method further includes providing a daily dosage regimen for administering the single oral dosage form to the patient to improve a nutritional status in the patient.

Abstract: A pharmaceutical composition comprising an active contraceptive drug and one or more pharmaceutically-acceptable excipients. The pharmaceutical composition, when subjected to an in vitro dissolution test according to the USP XXIII Paddle Method, results in no more than 50% of said active drug initially present being dissolved within 30 minutes, and at least 50% of the active drug being dissolved in a time range from about 3 hours to about 4 hours. The pharmaceutical composition is administered daily to a patient having a BMI of about 25 kg/m2 or more for at least a portion of a treatment cycle. The pharmaceutical composition does not cause a number of days of bleeding events in the patient exceeding an average of 15% per treatment cycle in consecutive treatment cycles of administration after an initial treatment cycle of administration.

Abstract: An easy entry seat assembly may include a seat frame having a seat bottom and a backrest supported for pivotal movement relative to the seat bottom. A reclining mechanism may be provided on the seat frame to selectively control pivotal movement of the backrest relative to the seat bottom. A backrest stopper mechanism may be provided on the seat frame. The backrest stopper mechanism may include an easy entry stopper that can be movable from a non-actuated position to an actuated position to stop pivotal movement of the backrest in an easy entry position. An easy entry actuator may be provided on the seat frame, wherein operation of the easy entry actuator can cause movement of the easy entry stopper to the actuated position and release the reclining mechanism.

Abstract: A device for assisting in the landing of an aircraft in a flare phase comprising a control stick, a first unit for acquiring current flight parameters of the aircraft, a second unit for acquiring a current deflection angle of the control stick, a computation unit for computing a difference between the current deflection angle of the control stick and a target deflection angle of the control stick, and an acoustic emission unit configured to automatically emit a warning or guidance sound signal in the cockpit of the aircraft, according to the difference between the current deflection angle and the target deflection angle of the control stick.

Abstract: A method and device for aiding the monitoring of a turbine engine of an aircraft, which displays on one and the same indicator of a of a display indication elements illustrating as a percentage the engine start progression or the current sub-idle state of the turbine engine, a margin to a limit temperature of the turbine engine, a margin to a maximum temperature of the turbine engine and a margin to a possible failure of the start that is generated by a too low speed increase of the turbine engine.

Abstract: A pharmaceutical composition comprising an active contraceptive drug and one or more pharmaceutically-acceptable excipients. The pharmaceutical composition, when subjected to an in vitro dissolution test according to the USP XXIII Paddle Method, results in no more than 50% of said active drug initially present being dissolved within 30 minutes, and at least 50% of the active drug being dissolved in a time range from about 3 hours to about 4 hours. The pharmaceutical composition is administered daily to a patient having a BMI of about 25 kg/m2 or more for at least a portion of a treatment cycle. The pharmaceutical composition does not cause a number of days of bleeding events in the patient exceeding an average of 15% per treatment cycle in consecutive treatment cycles of administration after an initial treatment cycle of administration.

Abstract: A balloon catheter system configured to deliver one or more stimulation signal to a tissue comprises an expandable balloon disposed around a distal portion of a catheter, a plurality of electrodes, and an external sheath having a lumen sized to slidably accommodate the expandable balloon, catheter and the plurality of electrodes. The plurality of electrodes are flexibly distributed along a balloon length and are configured to deliver the stimulation signals to the tissue. The plurality of electrodes may preferably be disposed on a flexible frame coupled externally of the expandable balloon and in sliding engagement to the balloon during inflation and deflation. The flexible frame may further comprise one or more sensors. The external sheath is made of a non-conductive material and is configured to prevent delivery of the stimulation signals by the electrodes disposed along an inoperable length of the expandable balloon when the balloon is inflated.

Abstract: A vehicle seat assembly having a seat bottom that includes first and second side frame members and a front cushion module. The front cushion module has a support wire and a cushion. The support wire has first and second ends that are disposed proximate the front end of the first and second side frame members, respectively. The cushion receives and is supported by the support wire.

Abstract: An easy entry seat assembly may include a seat frame having a seat bottom and a backrest supported for pivotal movement relative to the seat bottom. A reclining mechanism may be provided on the seat frame to selectively control pivotal movement of the backrest relative to the seat bottom. A backrest stopper mechanism may be provided on the seat frame. The backrest stopper mechanism may include an easy entry stopper that can be movable from a non-actuated position to an actuated position to stop pivotal movement of the backrest in an easy entry position. An easy entry actuator may be provided on the seat frame, wherein operation of the easy entry actuator can cause movement of the easy entry stopper to the actuated position and release the reclining mechanism.